the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Bagnaia takes first pole of 2025 season at Czech MotoGP

TWICE MotoGP champion Francesco Bagnaia claimed his first pole position of the season at the Czech Republic motorcycle Grand Prix on Saturday, edging out Ducati teammate Marc Marquez, who crashed on his final qualifying lap.

Bagnaia crossed the line with the fastest time of one minute and 52.303 seconds in mostly sunny conditions in Brno, with Marquez qualifying second and Yamaha’s Fabio Quartararo completing the front row.

Marquez was chasing an eighth pole of the season but slid into the gravel in the final minutes of second qualifying.

“I want to say thanks to my team – they did a fantastic job when I stopped for a little moment. We just did a little adjustment,“ Bagnaia said.

“It will be tricky for the tyres this afternoon,“ he added, referring to the Czech MotoGP sprint later on Saturday.

Reigning MotoGP champion Jorge Martin marked his return to qualifying with a 12th-place finish after missing 10 of the 11 rounds because of injuries.

Wrist and ankle injuries suffered in a pre-season crash had ruled the 27-year-old Martin out of the first three rounds before another crash in his first race on board the Aprilia bike in Qatar in April led to a collapsed lung and bruised ribs.

VR46 Racing’s Fabio Di Giannantonio, fourth in the riders’ championship, will start 13th on the grid after finishing third in qualifying one.

Marquez leads the riders’ championship table with 344 points, with his younger brother Alex second on 261. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings